BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing the novel, selective AXL kinase inhibitor bemcentinib for lung cancer announced today that the first ...
Back in the day, Larsen worked and studied under Gunnar Helland in downtown Fargo. Helland came from four generations of Hardanger Fiddle builders in Norway and he opened a shop in Fargo. Larsen, now ...
A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases remain rare. Here's what experts want you to know.